Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses

Reverse transcription of the retroviral genome is thought to start after virions enter target cells. Purified preparations of human immunodeficiency virus were found to contain virus-specific DNA, detectable by polymerase chain reaction amplification. This DNA resulted from reverse transcription in newly assembled virus particles and not from contamination by cellular DNA, because virions contained a striking excess of early versus late transcripts and because the accumulation of these products was sensitive to 3'-azido-3'-deoxythymidine (zidovudine) treatment of producer cells. A similar observation was made with murine amphotropic retrovirus particles. It is therefore likely that all retroviruses contain partial reverse transcripts.

[1]  J. Kappes,et al.  Human immunodeficiency virus type 2 vpx protein augments viral infectivity. , 1991, Virology.

[2]  R. Gallo,et al.  Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication , 1991, Journal of virology.

[3]  N. Besansky,et al.  Unintegrated human immunodeficiency virus type 1 DNA in chronically infected cell lines is not correlated with surface CD4 expression , 1991, Journal of virology.

[4]  D. Baltimore,et al.  The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Q. Sattentau,et al.  Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4 , 1991, Journal of virology.

[6]  Q. Sattentau,et al.  Dissociation of gp120 from HIV-1 virions induced by soluble CD4. , 1990, Science.

[7]  M. Stevenson,et al.  Integration is not necessary for expression of human immunodeficiency virus type 1 protein products , 1990, Journal of virology.

[8]  M. Stevenson,et al.  HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.

[9]  S. Spector,et al.  Human immunodeficiency virus pseudotypes with expanded cellular and species tropism , 1990, Journal of virology.

[10]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[11]  G. Daley,et al.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. , 1990, Science.

[12]  D. Baltimore,et al.  HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus , 1989, Cell.

[13]  D. Baltimore,et al.  Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression , 1989, Journal of virology.

[14]  B. Ho,et al.  Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity , 1989, Journal of virology.

[15]  M. Shibuya,et al.  Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. , 1985, Virology.

[16]  S. Goff,et al.  A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins , 1985, Journal of virology.

[17]  G. Shaw,et al.  Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. , 1984, Science.

[18]  R. Lerner,et al.  Nucleotide sequence of Moloney murine leukaemia virus , 1981, Nature.

[19]  R. Weinberg,et al.  In vitro synthesis of infectious DNA of murine leukaemia virus , 1977, Nature.

[20]  H. Varmus,et al.  Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA , 1977, Cell.

[21]  D. Baltimore,et al.  Increased length of DNA made by virions of murine leukemia virus at limiting magnesium ion concentration , 1977, Journal of virology.

[22]  M. Collett,et al.  Evidence for circularization of the avian oncornavirus RNA genome during proviral DNA synthesis from studies of reverse transcription in vitro. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Baltimore,et al.  Synthesis of Long, Representative DNA Copies of the Murine RNA Tumor Virus Genome , 1976, Journal of virology.

[24]  P. Duesberg,et al.  In vitro synthesis of full-length DNA transcripts of Rous sarcoma virus RNA by viral DNA polymerase. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Varmus,et al.  DNA of Rous Sarcoma Virus: Its Nature and Significance , 1972, Science.

[26]  B. McCain,et al.  The DNA of murine sarcoma-leukemia virus. , 1971, Virology.

[27]  G. Beaudreau,et al.  Viral DNA-dependent DNA Polymerase and the Properties of Thymidine Labelled Material in Virions of an Oncogenic RNA Virus , 1970, Nature.

[28]  R. Ray,et al.  Formation of Viral RNA–DNA Hybrid Molecules by the DNA Polymerase of Sarcoma-Leukaemia Viruses , 1970, Nature.

[29]  J. Bishop,et al.  Presence of DNA in Rous Sarcoma Virus , 1970, Nature.

[30]  J. Taylor,et al.  Retroid virus genome replication. , 1987, Advances in virus research.

[31]  S. Mizutani,et al.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus. , 1970, Nature.